Evelo Biosciences logo
Evelo Biosciences EVLO

Quarterly report 2023-Q3
added 11-09-2023

report update icon

Evelo Biosciences Total Current Liabilities 2011-2026 | EVLO

Annual Total Current Liabilities Evelo Biosciences

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
12.4 M 17.4 M 19.8 M 9.74 M 9.24 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
19.8 M 9.24 M 13.7 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Coherus BioSciences Coherus BioSciences
CHRS
140 M $ 1.57 -3.68 % $ 184 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
6.4 M - 1.35 % $ 17.8 M chinaChina
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
158 M $ 16.87 -2.49 % $ 789 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
36.4 M $ 7.47 -4.6 % $ 205 M israelIsrael
Athira Pharma Athira Pharma
ATHA
47.5 M - - $ 269 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
38.5 M $ 30.26 1.0 % $ 814 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
645 K - -32.59 % $ 7.61 M usaUSA
Exelixis Exelixis
EXEL
406 M $ 50.13 -1.9 % $ 13.6 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
49.7 M $ 2.41 4.78 % $ 67.2 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
20.8 M $ 23.11 -3.55 % $ 299 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
64.3 M $ 4.09 -7.05 % $ 1.22 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
73.4 M $ 1.63 2.52 % $ 434 M britainBritain
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
9.38 M - - $ 231 M usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
8.03 M $ 2.17 -7.66 % $ 139 M usaUSA
Berkeley Lights Berkeley Lights
BLI
45.5 M - -7.31 % $ 87 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
35.1 M - - $ 344 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Gilead Sciences Gilead Sciences
GILD
11.8 B $ 129.58 -1.88 % $ 161 B usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.73 M $ 3.36 -3.72 % $ 5.53 M israelIsrael
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
9.02 M $ 0.72 -1.58 % $ 32.9 M israelIsrael
Esperion Therapeutics Esperion Therapeutics
ESPR
301 M $ 3.12 - $ 649 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
9.71 M - 4.14 % $ 49.1 M usaUSA
Allakos Allakos
ALLK
17.8 M - - $ 28.6 M usaUSA